GLPG0634 5mg

GLPG0634 is an orally-available, selective inhibitor of JAK1 (Janus kinase 1) being developed by Galapagos for the treatment of rheumatoid arthritis and potentially other inflammatory diseases.

Price Not Available 5mg GLPG0634 5mg Supplier Page

Trivial name	GLPG0634 5mg
Catalog Number	A13162-5
Alternative Name(s)	N/A
Molecular Formula	C23H18N6O2
CAS#	1206101-20-3
SMILES	c1cc(n2c(c1)nc(n2)NC(=O)C3CC3)c4ccc(cc4)OCc5ccc(nc5)C#N
Size	5mg
Supplier Page	http://www.adooq.com/glpg0634.html